---
category: news
title: "AI Biomarker Approach for Prostate Cancer Therapy Shows Promise for Some Patients"
excerpt: "Data from a new study validates the first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer."
publishedDateTime: 2023-07-03T08:45:00Z
originalUrl: "https://www.technologynetworks.com/cancer-research/news/ai-biomarker-approach-for-prostate-cancer-therapy-shows-promise-for-some-patients-375596"
webUrl: "https://www.technologynetworks.com/cancer-research/news/ai-biomarker-approach-for-prostate-cancer-therapy-shows-promise-for-some-patients-375596"
type: article
quality: 49
heat: -1
published: false

provider:
  name: technologynetworks
  domain: technologynetworks.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://assets.technologynetworks.com/production/dynamic/images/content/375596/ai-biomarker-approach-for-prostate-cancer-therapy-shows-promise-for-some-patients-375596-640x360.jpg?cb=20230703"
    width: 640
    height: 360
    isCached: true

related:
  - title: "Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer"
    excerpt: "Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The study involved ArteraAI, a developer of multimodal artificial intelligence-based predictive and prognostic cancer tests,"
    publishedDateTime: 2023-06-30T21:30:00Z
    webUrl: "https://medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.html"
    ampWebUrl: "https://medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.amp"
    cdnAmpWebUrl: "https://medicalxpress-com.cdn.ampproject.org/c/s/medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.amp"
    type: article
    provider:
      name: Medical Xpress
      domain: medicalxpress.com
    quality: 55
    images:
      - url: "https://scx2.b-cdn.net/gfx/news/2021/prostate-cancer-2.jpg"
        width: 740
        height: 444
        isCached: true
  - title: "ArteraAI Announces First-Ever AI-Derived Biomarker for Predicting Androgen Deprivation Therapy (ADT) Benefit in Prostate Cancer"
    excerpt: "ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced today the publication of data in the NEJM Evidence, validating the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer."
    publishedDateTime: 2023-06-29T16:05:00Z
    webUrl: "https://www.kentuckytoday.com/news/business/arteraai-announces-first-ever-ai-derived-biomarker-for-predicting-androgen-deprivation-therapy-adt-benefit-in/article_c08e0cda-6eef-53b4-b28b-cfe718b52857.html"
    type: article
    provider:
      name: Kentucky Today
      domain: kentuckytoday.com
    quality: 26
    images:
      - url: "https://bloximages.newyork1.vip.townnews.com/kentuckytoday.com/content/tncms/custom/image/102b5a02-0453-11ec-9099-0b9a1e7cd50b.png?resize=600%2C315"
        width: 600
        height: 315
        isCached: true

secured: "g4218OamzE7pbBqoBOsTtMk8ge7OJhkPpv0B911qksbMEEfVLWTqp7AbJGcuUJ8DDd+7uTKr2yaem8hy25+Lzc4uStaWCfGWka+d8mCh7zdqn1OcXZ1knP55Qj8+VGqbNOjrkhlTIXrnssBbfmPrOE2oJOGjfHNFZMmkuPYz8ZXA32feGu6FoXjpGMPpe6pzbwvKNSXqkKYcCfR379WMPVsMT/b2eZ0/OSeJ3ljkmxG/jFq3uM5NKHC3SCRxAGERcU3Z8mY0SZ6wmBfBdzMj3a69lnF2fHyeW+WfmDv+4UhjmMZEN/r20P93w83x40jZsUXC4STgkuesRVEMDBDmwsSjOkU68Lmxr7eyNisCq2E=;EL77xAoSEJDWeu5q49k5Sw=="
---

